U.S. flag

An official website of the United States government

GTR Home > Laboratories > Phosphorus Diagnostics LLC

Phosphorus Diagnostics LLC

GTR Lab ID: 506283, Last updated:2020-12-01
Annual Review past due read more

Personnel

  • Director: Malgorzata Jaremko, PhD, MBA, ABMGG Board Certified, FACMG, Diplomate of the American Board of, Lab Director
  • Alexander Bisignano, Administrator

Conditions and tests

  • 3-methylglutaconic aciduria type 55 tests
  • Acute leukemia2 tests
  • Alstrom syndrome5 tests
  • Breast neoplasm1 test
  • Brugada syndrome1 test
  • Carcinoma of pancreas2 tests
  • Cardiac arrhythmia5 tests
  • Cardiomyopathy8 tests
  • Carnitine palmitoyltransferase II deficiency5 tests
  • Catecholaminergic polymorphic ventricular tachycardia1 test
  • Chronic pancreatitis1 test
  • Colorectal cancer1 test
  • Combined oxidative phosphorylation defect type 171 test
  • Congenital bilateral aplasia of vas deferens from CFTR mutation1 test
  • Congenital long QT syndrome1 test
  • COVID-192 tests
  • Familial melanoma1 test
  • Familial prostate carcinoma1 test
  • Fanconi anemia1 test
  • Hepatoencephalopathy due to combined oxidative phosphorylation defect type 14 tests
  • Hereditary antithrombin deficiency1 test
  • Hypercholesterolemia, familial, 11 test
  • Hypertrophic cardiomyopathy3 tests
  • Hypogonadotropic hypogonadism 24 without anosmia2 tests
  • Left ventricular noncompaction1 test
  • Male infertility1 test
  • Malignant neoplasm of brain1 test
  • Malignant tumor of thyroid gland1 test
  • Mitochondrial complex II deficiency, nuclear type 15 tests
  • Mitochondrial complex V (ATP synthase) deficiency nuclear type 25 tests
  • Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency1 test
  • Neoplasm3 tests
  • Ovarian cancer1 test
  • Papillary renal cell carcinoma type 11 test
  • Pearson syndrome1 test
  • Polycystic ovaries2 tests
  • Pregnancy loss, recurrent, susceptibility to, 21 test
  • Premature ovarian failure1 test
  • Premature ovarian failure 11 test
  • Primary dilated cardiomyopathy2 tests
  • Primary familial hypertrophic cardiomyopathy1 test
  • RASopathy7 tests
  • Restrictive cardiomyopathy1 test
  • Right ventricular cardiomyopathy1 test
  • Short QT syndrome1 test
  • Thrombophilia due to activated protein C resistance1 test
  • Thrombophilia due to protein C deficiency, autosomal dominant1 test
  • Thrombophilia due to protein S deficiency, autosomal dominant1 test
  • Very long chain acyl-CoA dehydrogenase deficiency5 tests

List of services

  • Clinical Testing/Confirmation of Mutations Identified Previously

List of certifications/licenses

Certifications

  • CLIAHelp, Number: 31D2123554, Expiration date: 2021-04-30
  • CAP, Number: 9504988, Expiration date: 2021-10-31

Licenses

  • CA - California Department of Public Health CDPH, Number: 00800772, Expiration date: 2021-10-22
  • FL - Florida Agency for Health Care Administration AHCA, Number: 800028531, Expiration date: 2021-03-31
  • MD - Maryland Department of Health and Mental Hygiene DHMH, Number: 2610, Effective date: 2019-04-10 Non-expiring
  • NJ - State of New jersey Department of Health and Senior Service, Number: 00044218, Expiration date: 2021-12-31
  • PA - Pennsylvania Department of Health PADOH, Number: 35494, Expiration date: 2021-08-15
  • RI - State of Rhode Island Department of Health RIDOH, Number: LCO01083, Expiration date: 2020-12-31

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.